# Dopl Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dopl-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Seattle, US
- Website: www.dopltechnologies.com/
- Total disclosed funding: $7.8M
- Latest round: Seed (Jul 27, 2026)
- Investors on record: 13

## About

Dopl Technologies Inc. is a Seattle-based company specializing in remote and autonomous ultrasound solutions, utilizing robotics and artificial intelligence to enhance diagnostic imaging for healthcare providers. Founded in 2022 and headquartered in Seattle, US, Dopl Technologies develops advanced ultrasound solutions focused on improving healthcare access. The company was co-founded by Ryan James(CEO) and Steve Seslar(COO). In July 2026, Dopl Technologies Inc. raised USD 6.3 million in seed funding led by new investor SpringTide Ventures, with participation from other new investors WRF Capital, HeartX, and VEP Ventures Manager, along with participation from returning investors Tacoma Venture Fund and Precursor Ventures. Otherangel investors also participated in the round. Dopl Technologies specializes in remote and autonomous ultrasound solutions, integrating robotics and artificial intelligence to enhance diagnostic imaging capabilities. Their core product, Dopl Traverse, facilitates high-quality ultrasound diagnostics regardless of geographical location, addressing healthcare access disparities in rural and workforce-constrained areas. This technology allows medical professionals to conduct imaging while maintaining clinical standards, catering to hospitals, healthcare providers, and sonographers in the US. Dopl Technologies generates revenue through partnership agreements and direct service contracts with healthcare facilities. The company's business model includes subscription services for continuous access to remote imaging solutions and transactional fees for individual diagnostic sessions, facilitating the incorporation of their advanced robotic ultrasound systems into existing hospital infrastructure. This pricing structure aligns with the enhanced patient outcomes and operational efficiency provided by their key offerings, such as Dopl Traverse. Dopl Technologies plans to utilize the USD 6.3 mn raised in Seed funding to support FDA clearance, product development, engineering growth, and commercialization of their remote ultrasound services aimed at underserved communities. The company is focused on expanding its market presence by launching new products in the upcoming years, although specific release dates have not been disclosed. Dopl aims to target additional geographic regions to further improve access to their diagnostic imaging solutions.

## Funding rounds

- Seed, Jul 27, 2026, $6.3M — WRF Capital, Precursor Ventures, Tacoma Venture Fund, HeartX, SpringTide Ventures, Transform Health Ventures
- Seed, Feb 4, 2025, $1.5M — University of Washington Endowment, Seattle Angel Conference, Precursor Ventures, Tacoma Venture Fund, The Pitch Fund, Measured Capital, NCW Tech Alliance, Washington State Black Angel Network, Dream Variation Ventures

## Investors

- University of Washington Endowment — Seed
- Seattle Angel Conference — Seed
- Precursor Ventures (https://capitalatlas.ai/funds/precursor-ventures) — Seed
- Tacoma Venture Fund (https://capitalatlas.ai/funds/tacoma-venture-fund) — Seed
- The Pitch Fund — Seed
- Measured Capital (https://capitalatlas.ai/funds/measured-capital) — Seed
- NCW Tech Alliance — Seed
- Washington State Black Angel Network — Seed
- Dream Variation Ventures — Seed
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Seed
- HeartX — Seed
- SpringTide Ventures — Seed
- Transform Health Ventures — Seed